Latest news
PMN Q2'26 Earnings: revenue estimate is 0 USD - TradingViewTradingView · Thu, 06 Aug 2026 11:00:16 GMTPMN: Interim results show PMN310 is safe and reduces key AD biomarkers, supporting target engagement - TradingViewTradingView · Tue, 28 Jul 2026 13:44:51 GMTPMN: Blinded 6-month interim data show strong safety and early biomarker signals in Alzheimer's patients - TradingViewTradingView · Tue, 28 Jul 2026 10:36:13 GMTPMN: Interim results show strong safety and biomarker improvements for PMN310 in Alzheimer's disease - TradingViewTradingView · Tue, 28 Jul 2026 07:00:00 GMT